Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.
about
Chapter 7: PharmacogenomicsVery important pharmacogene summary: thiopurine S-methyltransferaseBiased exon/intron distribution of cryptic and de novo 3' splice sitesPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseDrug methylation in cancer therapy: lessons from the TPMT polymorphismHuman thiopurine methyltransferase activity varies with red blood cell ageFrequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositusNew genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acidThe thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics.Murine pharmacogenomics: using the mouse to understand the genetics of drug therapy.Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groupsPhRMA white paper on ADME pharmacogenomics.Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.Thiopurine S-methyltransferase alleles, TPMT(*)2, (*)3B and (*)3C, and genotype frequencies in an Indian population.Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.
P2860
Q21563496-14433287-B2E2-4112-8A90-75B07F9E37A2Q24601748-43A01083-1354-443B-B41D-A87080BF8A8BQ24817064-68EAA4D9-BFB9-4BF9-931E-5269F43006B6Q28068930-5BC86348-298A-4F46-B09A-01F75A1F998BQ28212325-1E21EEE7-ADC6-4DAE-B0AB-AA0F5A09006AQ28365897-8D4369BC-57F1-4859-BE10-76E0143C4196Q28367534-BF348BE1-DEA0-4A47-A3FF-5B02E23C135DQ28538238-3E6616C0-ADAF-4D7A-A4D0-D334C334758CQ34609157-6A1D60D6-B5E9-40CD-823C-485DC139FC7CQ35000912-02CB0854-5287-418F-B6C8-8D0C6297AA56Q35826329-96577847-C705-4A8E-A8ED-EDD98CCC0524Q37182212-1E2BB01C-47D1-43A7-973A-2988D3F1DC1DQ39113625-0F0E797A-A315-47ED-BB69-0BD025DB89BBQ41459673-0B34E768-F19A-46B6-8684-A561F7AA594FQ48191847-8C7BFDCC-BA9C-4389-95C1-D8A71C19F0C5
P2860
Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human thiopurine methyltransfe ...... t results in loss of activity.
@en
Human thiopurine methyltransfe ...... t results in loss of activity.
@nl
type
label
Human thiopurine methyltransfe ...... t results in loss of activity.
@en
Human thiopurine methyltransfe ...... t results in loss of activity.
@nl
prefLabel
Human thiopurine methyltransfe ...... t results in loss of activity.
@en
Human thiopurine methyltransfe ...... t results in loss of activity.
@nl
P2093
P2860
P356
P1476
Human thiopurine methyltransfe ...... t results in loss of activity.
@en
P2093
C L Szumlanski
D M Otterness
R M Weinshilboum
P2860
P304
P356
10.1172/JCI1004
P407
P577
1998-03-01T00:00:00Z